Autophagy in Load-Induced Heart Disease

被引:167
作者
Rothermel, Beverly A.
Hill, Joseph A. [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Div Cardiol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA
关键词
autophagy; cardiac hypertrophy; heart failure; hypertrophy; signal transduction;
D O I
10.1161/CIRCRESAHA.108.186551
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The heart is a highly plastic organ capable of remodeling in response to changes in physiological or pathological demand. For example, when workload increases, compensatory hypertrophic growth of individual cardiomyocytes occurs to increase cardiac output. Sustained stress, however, such as that occurring with hypertension or following myocardial infarction, triggers changes in energy metabolism and sarcomeric protein composition, loss of cardiomyocytes, ventricular dilation, reduced pump function, and ultimately heart failure. It has been known for some time that autophagy is active in cardiomyocytes, occurring at increased levels in disease. Now, with recent advances in our understanding of molecular mechanisms governing autophagy, the potential contributions of cardiomyocyte autophagy to ventricular remodeling and disease pathogenesis are being explored. As part of this work, several recent studies have focused on autophagy in heart disease elicited by changes in hemodynamic load. Pressure overload stress elicits a robust autophagic response in cardiomyocytes that is maladaptive, contributing to disease progression. In this context, load-induced aggregation of intracellular proteins is a proximal event triggering autophagic clearance mechanisms. These findings in the setting of pressure overload contrast with protein aggregation occurring in a model of protein chaperone malfunction, where activation of autophagy is beneficial, antagonizing disease progression. Here, we review recent studies of cardiomyocyte autophagy in load-induced disease and address molecular mechanisms and unanswered questions. (Circ Res. 2008;103:1363-1369.)
引用
收藏
页码:1363 / 1369
页数:7
相关论文
共 75 条
[1]   Thioredoxin1 as a negative regulator of cardiac hypertrophy [J].
Ago, Tetsuro ;
Sadoshima, Junichi .
ANTIOXIDANTS & REDOX SIGNALING, 2007, 9 (06) :679-687
[2]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[3]   Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake [J].
Chen, QH ;
Liu, JB ;
Horak, KM ;
Zheng, HQ ;
Kumarapeli, ARK ;
Li, J ;
Li, FQ ;
Gerdes, AM ;
Wawrousek, EF ;
Wang, XJ .
CIRCULATION RESEARCH, 2005, 97 (10) :1018-1026
[5]   LYSOSOMAL VACUOLAR APPARATUS OF CARDIAC MYOCYTES IN HEART OF STARVED AND REFED RABBITS [J].
DECKER, RS ;
DECKER, ML ;
HERRING, GH ;
MORTON, PC ;
WILDENTHAL, K .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1980, 12 (11) :1175-1189
[6]  
DECKER RS, 1980, AM J PATHOL, V98, P425
[7]   The fuzzy logic of physiological cardiac hypertrophy [J].
Dorn, Gerald W., II .
HYPERTENSION, 2007, 49 (05) :962-970
[8]   Phenotyping hypertrophy - Eschew obfuscation [J].
Dorn, GW ;
Robbins, J ;
Sugden, PH .
CIRCULATION RESEARCH, 2003, 92 (11) :1171-1175
[9]   Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death [J].
Elsässer, A ;
Vogt, AM ;
Nef, H ;
Kostin, S ;
Möllmann, H ;
Skwara, W ;
Bode, C ;
Hamm, C ;
Schaper, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2191-2199
[10]   Hypertrophy of the heart - A new therapeutic target? [J].
Frey, N ;
Katus, HA ;
Olson, EN ;
Hill, JA .
CIRCULATION, 2004, 109 (13) :1580-1589